Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
News May 09, 2007
Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.
Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019